In-111 Zevalin Interactions
There are 359 drugs known to interact with In-111 Zevalin (ibritumomab), along with 3 disease interactions. Of the total drug interactions, 134 are major, 222 are moderate, and 3 are minor.
- View all 359 medications that may interact with In-111 Zevalin
- View In-111 Zevalin disease interactions (3)
Most frequently checked interactions
View interaction reports for In-111 Zevalin (ibritumomab) and the medicines listed below.
- Cardiolite (sestamibi)
- Ceretec (exametazime)
- Choletec (mebrofenin)
- clonazepam
- DTPA (pentetic acid)
- Hepatolite (disofenin)
- indium chloride in-111
- MAA (albumin aggregated)
- MDP-25 (medronic acid)
- Neurolite (bicisate dihydrochloride)
- Persantine IV (dipyridamole)
- Pulmolite (albumin aggregated)
- Quadramet (samarium sm 153 lexidronam)
- sodium iodide i-123
- sodium iodide-i-131
- sodium pertechnetate (tc-99m)
- sulfur colloid
- TechneScan HDP (oxidronate)
In-111 Zevalin disease interactions
There are 3 disease interactions with In-111 Zevalin (ibritumomab) which include:
Report options
QR code containing a link to this page
More about In-111 Zevalin (ibritumomab)
- In-111 Zevalin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
